DNA X, Inc. SONM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -24.31% | 4.17% | -16.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -24.31% | 4.17% | -16.41% |
| Cost of Revenue | -- | -- | -60.48% | -33.36% | -53.13% |
| Gross Profit | -- | -- | -73.63% | -88.46% | -71.58% |
| SG&A Expenses | -- | -- | 74.39% | -24.99% | -17.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 74.39% | -14.99% | -28.73% |
| Operating Income | -- | -- | -74.39% | -118.23% | -170.48% |
| Income Before Tax | -- | -- | -175.93% | -123.98% | -168.91% |
| Income Tax Expenses | -- | -- | -67.74% | -90.05% | -81.77% |
| Earnings from Continuing Operations | -- | -- | -175.93% | -118.03% | -160.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | 38.61% | -149.38% | -200.96% |
| EBIT | -- | -- | -74.39% | -118.23% | -170.48% |
| EBITDA | -- | -- | -342.01% | -171.06% | -240.61% |
| EPS Basic | -- | -- | 79.02% | -86.36% | -150.49% |
| Normalized Basic EPS | -- | -- | 18.62% | -75.86% | -138.21% |
| EPS Diluted | -- | -- | 79.02% | -86.41% | -150.24% |
| Normalized Diluted EPS | -- | -- | 18.62% | -75.86% | -137.80% |
| Average Basic Shares Outstanding | -- | -- | 146.57% | 106.54% | 40.67% |
| Average Diluted Shares Outstanding | -- | -- | 146.57% | 106.54% | 39.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |